Marco Donia, Research Group Leader of the TIL group at CCIT (Center for Cancer Immune Therapy) and Professor at the University of Copenhagen, shared a post on LinkedIn:
“Impact of Real-World Data on Immunotherapy Treatment Guidelines (Slides available)
Delighted to give this talk at the Norwegian Oncology Forum 2025, a phenomenal event organized every year by Norwegian oncologists and cancer researchers with focus on National and International innovation and collaboration.
My presentation (edited slides) can be downloaded.
If you want to know more about how drug agencies use Real-World Data for regulatory and reimbursement decisions, check at the links below:
Thanks for this invite and congratulations to the brilliant organizing committee for setting up such an incredible event.”
More posts featuring Marco Donia.